Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Sio Gene Therapies Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 41 | 38 | −3 |
| Shares | 20.7M | 21.1M | +434.7K (+2.1%) |
| Value | $7.44M | $5.91M | −$1.53M (−20.6%) |
New holders (1)
Institutions that held Sio Gene Therapies Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boston Private Wealth LLC | 94,150 | $26.0K | 0.00% |
Sold out (4)
Institutions that held Sio Gene Therapies Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 57,187 | $20.0K |
| D. E. Shaw & Co., Inc. | 23,028 | $8.00K |
| Dimensional Fund Advisors LP | 20,749 | $7.00K |
| Captrust Financial Advisors | 1,018 | $0 |